Investment - Articles - Aviva announce bulk annuity deal with Wyeth Group Pension


Aviva have announced it has completed a £190m bulk purchase annuity buy-in transaction with the Trustees of the Wyeth Group Pension and Life Assurance Scheme (1997). The sponsoring employer, John Wyeth & Brother Limited, is part of the Pfizer Group which is one of the world’s largest biopharmaceutical companies.

 Aviva will insure the defined benefit (DB) pension liabilities for approximately 2000 members, removing the investment and longevity risk of these members from the Scheme. The transaction also makes use of Aviva’s innovative Defined Benefit and Contribution Plan, which will ultimately secure benefits for those members with both defined benefit and defined contribution (DC) arrangements following a period after the initial buy-in transaction.

 The process to select an insurer and negotiate terms was led by Mercer on behalf of the Trustees, with Allen & Overy LLP providing legal advice.

 Jamie Cole, Head of Bulk Purchase Annuity Origination at Aviva, said: “We’ve worked closely with the Trustees and their advisers and are delighted to have helped secure benefits for these members. Our Defined Benefit and Contribution Plan allows both DB and DC arrangements to continue to be held under a single arrangement with Aviva, providing the members with greater flexibility at retirement”.

 Debbie Berney, Chair of Trustees Wyeth Group Pension and Life Assurance Scheme, said: “We welcome this transaction as our second phase in ensuring the Scheme is able to meet the full costs of its future pension payments to all members. This has only been achieved by considerable dedication from the Trustees working in partnership with their advisors Mercer, Allen & Overy and FTI Consulting, to achieve this attractive transaction with Aviva, as part of the de-risking plan for the Scheme.”

 Patrick McKenna, Senior Director International Pensions at Pfizer, said: “This is another important step for the Scheme and wider Group as we seek to secure members’ benefits and reduce the risk exposures of our pension arrangements. Aviva put forward attractive pricing and innovative proposals to address a complex set of benefits, and we are pleased to partner with them on this transaction."

 Deborah McWhinney, Risk Transfer Principal at Mercer, said: “We are delighted to have been able to work with the Trustees to bring the Scheme to the market and achieve such a successful transaction. This is an important milestone for the Trustees in their de-risking journey and represents an impressive outcome for the long term security of members’ benefits.”

 Suthan Rajagopalan, Risk Transfer Partner at Mercer, said: “As a follow on to the Trustees’ pensioner buy-in in 2018, the challenge was how to cost effectively insure the residual deferred pensioners. Mercer was pleased to deliver the Trustees both highly competitive market pricing and terms, including a price lock to Scheme assets. This deal’s attractive pricing was in part driven by the trend of improved longevity reinsurer appetite and innovation for deferred pensioner pricing which Aviva was able to tap into for the benefit of the Scheme’s membership as a whole.”
  

Back to Index


Similar News to this Story

FCA closes 1600 websites as it fights financial crime
The FCA’s annual report sets out how it has used data and technology to crack down on harm in financial services. Over 1,600 websites suspected of pro
Fresh tariffs threats knock sentiment
The US President has ratcheted up his threats against Canada promising duties of 35% on imports. The UK economy contracted in May by 0.1%, with a drop
Nvidia hits USD4tn as the boy crying tariffs warbles on
The FTSE 100 tip-toed higher again with another nudge towards the record it set last month says AJ Bell Head of Financial Analysis Danni Hewson.

Site Search

Exact   Any  

Latest Actuarial Jobs

Actuarial Login

Email
Password
 Jobseeker    Client
Reminder Logon

APA Sponsors

Actuarial Jobs & News Feeds

Jobs RSS News RSS

WikiActuary

Be the first to contribute to our definitive actuarial reference forum. Built by actuaries for actuaries.